Skip to main content
Clinical Trials/CTRI/2022/12/048431
CTRI/2022/12/048431
Not yet recruiting
未知

A single blinded, randomized controlled trial comparing the efficacy and safety of 1% Luliconazole cream plus 1% CiclopiroxOlamine cream, 1% Luliconazole cream plus 0.25% Amorolfine cream and 1% Luliconazole cream alone in the treatment of Tinea Corporis and Tinea cruris.

SRM Medical College Hospital & Research Centre, SRMIST, Potheri0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B354- Tinea corporis
Sponsor
SRM Medical College Hospital & Research Centre, SRMIST, Potheri
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
SRM Medical College Hospital & Research Centre, SRMIST, Potheri

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of age 18years to 60 years, attending dermatology OPD of our hospital, and diagnosed to have Tinea corporis/cruris
  • 2\. Positive KOH mount test from skin scraping
  • 3\. Patients With mild to moderate extent of disease (less than 10% BSA involvement) and who are suitable for topical\-only antifungal therapy.

Exclusion Criteria

  • 1\.Patients with known allergy to azole antifungals, Amorolfine or Ciclopiroxolamine.
  • 2\.Pregnancy/ lactation
  • 3\.Patients with dermatophytosis affecting nails / scalp/ palms / soles
  • 4\.Patients with clinical features suggestive of secondary bacterial infections
  • 5\.Patients on immunosuppressive therapy
  • 6\.Patients who had used any topical medications for the tinea corporis/cruris lesions, in the last 2 weeks, or any systemic antifungal medications in the last 1 month.
  • 7\.Patients who are not willing to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials